B&K CORP-B 02396Hong Kong Stock Exchange

4.1957.29%( +0.285 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
B&K CORP-B (02396) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
B&K Corp Ltd
Market
HKEX Main Board
Listing Date
2025-12-22
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE100007CT6

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)612.13K111/112
Net Profit (Last FY)-245.07M85/125
ROE (Last FY)-33.46%92/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
JIA Lijia Executive Director
WANG Kelong Executive Director
ZHAI Junhui Executive Director
MIAO Tianxiang Executive Director
LIN Ying Non-Executive Director
YUAN Fei Non-Executive Director
FOK Chi Tat Michael Independent Non-Executive Director
LI Jiayan Independent Non-Executive Director
YUE Yichun Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-12-19.

About this page

This page shows B&K CORP-B (02396) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.